Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficiency and Safety of Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19: A Randomized Clinical Trial

NCT04910230 is registered in ClinicalTrials.gov with Qiang Hu as lead sponsor.

NCT NCT04910230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04910230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficiency and Safety of Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19: A Randomized Clinical Trial
Lead sponsor
Qiang Hu
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2020
Completion date
April 2, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, lymphopenia